阴道微环境失衡与高危型人乳头瘤病毒持续感染

doi:10.3877/cma.j.issn.1673-5250.2021.06.017

目的

探讨阴道微生态失衡与高危型人乳头瘤病毒(HR-HPV)持续感染的关系。

方法

选择2014年1月至2015年12月，在四川省科学城医院妇科诊断为HR-HPV感染的240例患者为研究对象，年龄为19~73岁。根据HR-HPV感染状态，将其分为研究组(n＝121，HR-HPV持续感染者)和对照组(n＝119，HR-HPV复查呈阴性者)。采用成组t检验，对2组患者的体重、人体质量指数(BMI)、孕次、产次等进行统计学分析。采用χ²检验，对2组患者的细菌性阴道病(BV)、外阴阴道假丝酵母菌病(VVC)、滴虫性阴道炎(TV)、需氧菌性阴道炎(AV)发生率等进行统计学分析。本研究遵循的程序符合2013年修订的《世界医学协会赫尔辛基宣言》要求。

结果

①2组受试者体重、BMI、孕次和产次等一般临床资料比较，差异均无统计学意义(P>0.05)。②研究组患者BV、VVC检出率分别为43.0%(52/121)、38.0%(46/121)，明显高于对照组的20.2%(24/119)、15.1%(18/119)，2组比较，差异均有统计学意义(χ²＝14.422、16.075，P＝0.002、<0.001)。研究组和对照组患者的TV、AV和混合性感染患者检出率比较，差异均无统计学意义(P>0.05)。

结论

BV、VVC与HR-HPV持续性感染密切相关，改善阴道微生态环境可能有助于降低HR-HPV的发生率。

关键词: 阴道, 人乳头瘤病毒, 感染, 阴道病，细菌性, 念珠菌病，外阴阴道, 滴虫性阴道炎, 女(雌)性

Objective

To investigate relationship between vaginal microecological imbalance and persistent high-risk human papillomavirus (HR-HPV) infection.

Methods

From January 2014 to December 2015, a total of 240 patients, aged 19-73 years old, diagnosed with HR-HPV infection in Department of Gynecology, Science City Hospital of Sichuan. According to HR-HPV infection statuses, they were divided into study group (n=121, those who with persistent HR-HPV infection) and control group (n=119, those who with negative HR-HPV retest). Independent-samples t test was used to statistically analyze weight, body mass index (BMI), gravidity and parity between two groups. The incidence of bacterial vaginosis (BV), vulvovaginal pseudo vaginosis (VVC), trichomoniasis vaginosis (TV), and aerobic vaginitis (AV) between 2 groups were statistically analyzed by chi-square test. The procedures followed in this study were in accordance with the requirements of the World Medical Association Declaration of Helsinki revised in 2013.

Results

① There were no statistically significant differences in general clinical data such as weight, BMI, gravidity and parity between 2 groups (P>0.05). ②The detection rates of BV and VVC in study group were 43.0% (52/121) and 38.0% (46/121), respectively, which were significantly higher than those 20.2% (24/119) and 15.1% (18/119) in control group, and differences were statistically significant (χ²=14.422, 16.075; P=0.002, <0.001). Besides, the differences were not statistically significant in detection rates of TV, AV between 2 groups (P>0.05).

Conclusions

BV and VVC are closely associated with persistent HR-HPV infection, and improving the vaginal microecological environment may help to reduce the incidence of HR-HPV.

Key words: Vagina, Human papillomavirus, Infection, Vaginosis, bacterial, Candidiasis, vulvovaginal, Trichomonas vaginitis, Female

表1 2组患者一般临床资料比较(±s)

组别	例数	体重(kg)	BMI(kg/m²)	孕次(次)	产次(次)
研究组	121	61.1±6.5	23.7±2.0	2.12±0.03	1.31±0.03
对照组	119	61.0±6.3	23.5±2.4	2.15±0.01	1.33±0.02
t值		0.121	0.702	<0.001	<0.001
P值		0.452	0.242	0.999	0.999

表1 2组患者一般临床资料比较(±s)

组别	例数	体重(kg)	BMI(kg/m²)	孕次(次)	产次(次)
研究组	121	61.1±6.5	23.7±2.0	2.12±0.03	1.31±0.03
对照组	119	61.0±6.3	23.5±2.4	2.15±0.01	1.33±0.02
t值		0.121	0.702	<0.001	<0.001
P值		0.452	0.242	0.999	0.999

表2 2组患者阴道分泌物检测异常情况比较[例数(%)]

组别	例数	BV	VVC	TV	AV	混合性感染
研究组	121	52(43.0)	46(38.0)	13(10.7)	19(15.7)	15(12.4)
对照组	119	24(20.2)	18(15.1)	10(8.4)	10(8.4)	10(8.4)
χ²值		14.422	16.075	0.379	3.009	1.025
P值		0.002	<0.001	0.538	0.083	0.311

表2 2组患者阴道分泌物检测异常情况比较[例数(%)]

组别	例数	BV	VVC	TV	AV	混合性感染
研究组	121	52(43.0)	46(38.0)	13(10.7)	19(15.7)	15(12.4)
对照组	119	24(20.2)	18(15.1)	10(8.4)	10(8.4)	10(8.4)
χ²值		14.422	16.075	0.379	3.009	1.025
P值		0.002	<0.001	0.538	0.083	0.311

[1]	Li T, Liu ZH, Li K, et al. Evaluation of the vaginal microbiome in clinical diagnosis and management of vaginal infectious diseases[J]. Chin Med J (Engl), 2019, 132(9)：1100-1103. DOI: 10.1097/CM9.0000000000000211.
[2]	Lu Y, Xu X, Nong XH, et al. Detection of high-risk human papillomavirus DNA in sentinel lymph nodes of patients with cervical cancer[J]. Oncol Lett, 2020, 19(3)：2317-2325. DOI: 10.3892/ol.2020.11337.
[3]	Chao X, Sun T, Wang S, et al. Research of the potential biomarkers in vaginal microbiome for persistent high-risk human papillomavirus infection[J]. Ann Transl Med, 2020, 8(4)：100. DOI: 10.21037/atm.2019.12.115.
[4]	Weston G, Dombrowski C, Harvey MJ, et al. Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluation[J]. BMJ Open, 2020, 10(3)：e031303. DOI: 10.1136/bmjopen-2019-031303.
[5]	Vos RA, Pasmans H, Tymchenko L, et al. High seroprevalence of multiple high-risk human papillomavirus types among the general population of Bonaire, St. Eustatius and Saba, Caribbean Netherlands[J]. Vaccine, 2020, 38(13)：2816-2826. DOI: 10.1016/j.vaccine.2020.02.017.
[6]	Castle PE, Varallo JE, Bertram MM, et al. High-risk human papillomavirus prevalence in self-collected cervicovaginal specimens from human immunodeficiency virus (HIV)-negative women and women living with HIV living in Botswana[J]. PLoS One, 2020, 15(2)：e0229086. DOI: 10.1371/journal.pone.0229086.
[7]	Pańczyszyn A, Boniewska-Bernacka E, Gīąb G. Telomere length in leukocytes and cervical smears of women with high-risk human papillomavirus (HR HPV) infection[J]. Taiwan J Obstet Gynecol, 2020, 59(1)：51-55. DOI: 10.1016/j.tjog.2019.11.007.
[8]	Manley KM, Luker R, Park C. An audit of liquid-based cytology samples reported as high-risk human papillomavirus and borderline nuclear change in endocervical cells[J]. Cytopathology, 2020, 31(2)：130-135. DOI: 10.1111/cyt.12803.
[9]	Sangpichai S, Patarapadungkit N, Pientong C, et al. Chlamydia trachomatis infection in high-risk human papillomavirus based on cervical cytology specimen[J]. Asian Pac J Cancer Prev, 2019, 20(12)：3843-3847. DOI: 10.31557/APJCP.2019.20.12.3843.
[10]	Zhao S, Zhao XL, Hu SY, et al.Comparison of high-risk human papillomavirus infection rate and genotype distribution between Han and Mongolian women[J]. Chin J Epidemiol, 2019, 40(11)：1439-1444. DOI: 10.3760/cma.j.issn.0254-6450.2019.11.018.
[11]	Cao M, Wang Y, Wang D, et al. Increased high-risk human papillomavirus viral load is associated with immunosuppressed microenvironment and predicts a worse long-term survival in cervical cancer patients[J]. Am J Clin Pathol, 2020, 153(4)：502-512. DOI: 10.1093/ajcp/aqz186.
[12]	Negi SS, Bhargava A, Singh P, et al. Predominance of high-risk human papillomavirus genotype 16 and 39 in women with premalignant and malignant cervical pathology from Raipur, Chhattisgarh: clinical evaluation of tagging oligonucleotide cleavage and extension mediated genotyping assay[J]. Indian J Med Microbiol, 2019, 37(2)：255-262. DOI: 10.4103/ijmm.IJMM_19_162.
[13]	Nikouyan N, Farhadi A, Gorzin AA, et al. A fluorometric hybridization assay for detecting and genotyping high-risk human papillomavirus 16 and 18 in archival tissues of cervical specimens[J]. Braz J Microbiol, 2020, 51(1)：161-168. DOI: 10.1007/s42770-019-00137-8.
[14]	Kim J, Jun SY. Analytic performance of PANArray HPV and HPV 9G DNA chip tests for genotyping of high-risk human papillomavirus in cervical ThinPrep PreservCyt samples[J]. PLoS One, 2019, 14(10)：e0224483. DOI: 10.1371/journal.pone.0224483.
[15]	Schiffman M, Kjaer SK. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia[J]. J Natl Cancer Inst Monogr, 2003, (31)：14-19. DOI: 10.1093/oxfordjournals.jncimonographs.a003476.
[16]	周芳芳，史娜娜. 妊娠期糖尿病孕妇阴道微生态变化及其对妊娠结局的影响[J/CD]. 中华妇幼临床医学杂志(电子版), 2020, 16(6): 714-719. DOI: 10.3877/cma.j.issn.1673-5250.2020.06.014.
[17]	Surriabre P, Torrico A, Vargas T, et al. Assessment of a new low-cost, PCR-based strategy for high-risk human papillomavirus DNA detection for cervical cancer prevention[J]. BMC Infect Dis, 2019, 19(1)：842. DOI: 10.1186/s12879-019-4527-9.
[18]	张碧云，肖小敏，钟兴明，等. 肠道菌群紊乱与女性生殖内分泌疾病相关性研究现状[J/CD]. 中华妇幼临床医学杂志(电子版), 2021, 17(4): 488-491. DOI: 10.3877/cma.j.issn.1673-5250.2021.04.017.
[19]	Siegler E, Reichman Y, Kugelman N, et al. Low-risk human papillomavirus types in cervical intraepithelial neoplasia 2-3 and in invasive cervical cancer patients[J]. J Low Genit Tract Dis, 2019, 23(4)：248-252. DOI: 10.1097/LGT.0000000000000486.
[20]	Salambanga C, Zohoncon TM, Traoré I, et al. High prevalence of high-risk human papillomavirus (HPV) infection among sexually active women in Ouagadougou[J]. Med Sante Trop, 2019, 29(3)：302-305. DOI: 10.1684/mst.2019.0920.
[21]	Luckett R, Mogowa N, Li HJ, et al. Performance of two-stage cervical cancer screening with primary high-risk human papillomavirus testing in women living with human immunodeficiency virus[J]. Obstet Gynecol, 2019, 134(4)：840-849. DOI: 10.1097/AOG.0000000000003496.
[22]	杨少岩，赵卫东. 阴道微环境改变与宫颈癌相关性的研究进展[J]. 深圳中西医结合杂志，2017, 27(6)：4.

[1]	包艳娟, 杨小红, 张涛, 赵胜, 张莉. 阴道斜隔综合征的超声诊断与临床分析[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(09): 859-864.
[2]	农云洁, 黄小桂, 黄裕兰, 农恒荣. 超声在多重肺部感染诊断中的临床应用价值[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(09): 872-876.
[3]	刘欢, 邢皓, 常正奇, 张记. 机械敏感性离子通道蛋白Piezo1在感染相关疾病中的研究进展[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 263-269.
[4]	黄鸿初, 黄美容, 温丽红. 血液系统恶性肿瘤患者化疗后粒细胞缺乏感染的危险因素和风险预测模型[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 285-292.
[5]	梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[6]	许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[7]	刘柏隆, 周祥福. 经阴道膀胱膨出前盆补片修补术 + 阴道后壁修补术[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 128-128.
[8]	皮尔地瓦斯·麦麦提玉素甫, 李慧灵, 艾克拜尔·艾力, 李赞林, 王志, 克力木·阿不都热依木. 生物补片修补巨大复发性腹壁切口疝临床疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 624-628.
[9]	顾熙, 徐子宇, 周澍, 张吴楼, 张业鹏, 林昊, 刘宗航, 嵇振岭, 郑立锋. 腹股沟疝腹膜前间隙无张力修补术后补片感染10 例报道[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 665-669.
[10]	臧宇, 姚胜, 朱新勇, 戎世捧, 田智超. 低温等离子射频消融治疗腹壁疝术后补片感染的临床效果[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 687-692.
[11]	杨闯, 马雪. 腹壁疝术后感染的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 693-696.
[12]	中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[13]	丛黎, 马林, 陈旭, 李文文, 张亮亮, 周华亭. 改良CT严重指数联合炎症指标在重症急性胰腺炎患者胰腺感染预测及预后评估中的研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 432-436.
[14]	贾玲玲, 滕飞, 常键, 黄福, 刘剑萍. 心肺康复在各种疾病中应用的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 859-862.
[15]	颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Vaginal microenvironmental imbalance and persistent infection with high-risk human papillomavirus

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Vaginal microenvironmental imbalance and persistent infection with high-risk human papillomavirus